Wednesday, July 9, 2025
HomeIndustriesBiotechnology

Biotechnology

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Kintara Therapeutics, Inc.("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the Company received...

NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody

NanoMosaic, the pioneer and leader of nanoneedle technology (MosaicNeedle™) for proteomics and multi-omics, is increasing its capabilities in neurology companion diagnostics (CDx) and future...

WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

WuXi Biologics ("WuXi Bio") , a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility...

CStone and Pfizer Announce NMPA Approval of Sugemalimab in Patients With Unresectable Stage Iii Non-small Cell Lung Cancer

CStone Pharmaceuticals, a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, and Pfizer Inc. announced that...

Imaging Endpoints (IE) and ImaginAb Inc Expand Partnership – IE to Supply Clinical Doses of CD8 Imaging Agent to BioPharma Companies

Imaging Endpoints (IE) and ImaginAb announced that after collaborating for nearly a decade they have entered into a license agreement for IE to directly...
0FansLike
0FollowersFollow
spot_img

Hot Topics